share_log

Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?

Major Cannabis Merger Approved In New York: Can Weed Stock Investors Take Advantage?

纽约批准了一项重大的大麻股合并:大麻股投资者能否抓住机会?
Benzinga ·  10/10 17:21

RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) and Cansortium Inc. (CSE:TIUM) (OTCQB:CNTMF) have secured approval from the New York Cannabis Control Board for their upcoming merger, marking a major consolidation in the state's fast-growing cannabis industry.

RIV Capital Inc. (CSE:RIV)(OTC:CNPOF)和Cansortium Inc.(CSE:TIUM)(OTCQB:CNTMF)已获得纽约大麻股管理局批准进行即将到来的合并,标志着该州快速增长的大麻行业即将发生重大整合。

The merger, expected to close by the end of 2024, positions the combined company to take full advantage of covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

预计合并将于2024年底完成,使合并后的公司能充分利用覆盖美国25%人口的优势,拥有8个种植加工设施和42家零售药店。

"We are thrilled to have received regulatory approval in New York to move forward with our business combination transaction, bringing us closer to completing this important step for both of our companies in the fourth quarter of 2024," said Robert Beasley, CEO of Cansortium, in a press release Thursday afternoon.

“我们很高兴获得纽约的监管机构批准,以推动我们的业务组合交易,使我们更接近于在2024年第四季度完成两家公司的重要步骤,”Cansortium首席执行官罗伯特·比斯利在周四下午的新闻发布会上表示。

  • Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you're serious about the business.
  • 在Benzinga获取独家分析,并每天免费获得关于大麻业务和市场的头条新闻。立即订阅我们的通讯,认真对待业务,您不容错过。

New York's Cannabis Boom

纽约的大麻繁荣

With adult-use cannabis sales now in full swing, New York has quickly become a battleground for companies looking to expand their market share. RIV Capital, which operates three retail locations in the state, has seen rapid growth in both its consumer-facing and wholesale businesses since adult-use sales began earlier this year.

随着成年人使用大麻销售进入全面推广,纽约迅速成为企业竞相扩大市场份额的战场。在该州经营三家零售店的RIV Capital自今年早些时候开始成年人使用销售以来,其面向消费者和批发业务都实现了快速增长。

Cansortium, a vertically integrated company operating under the FLUENT brand, brings significant expertise from other key markets, including Florida, Pennsylvania, and Texas.

作为一家在FLUENt品牌下运营的垂直一体化公司,Cansortium在佛罗里达、宾夕法尼亚和德克萨斯等其他关键市场拥有重要经验。

Read Also: EXCLUSIVE: 80% Growth Despite The Chaos: How Dutchie, C3 Defy 2024's Cannabis Slump

阅读更多:独家报道:尽管混乱,Dutchie、C3仍然实现了80%的增长:如何抵御2024年的大麻低迷

What This Means For Investors

对投资者意味着什么

For cannabis investors, this merger signals a unique opportunity to gain exposure to a rapidly expanding market. RIV Capital's partnership with The Hawthorne Collective, a subsidiary of ScottsMiracle-Gro (NYSE:SMG), further strengthens its position in the cannabis supply chain. Meanwhile, Cansortium's operational expertise in cultivation, production and retail will likely drive significant value for shareholders.

对于大麻股投资者,这次合并预示着一个独特的机会,可以在一个快速扩张的市场中获得曝光。RIV Capital与ScottsMiracle-Gro(纽交所:SMG)旗下的The Hawthorne Collective合作,进一步巩固了其在大麻供应链中的地位。与此同时,Cansortium在种植、生产和零售方面的运营专业知识可能会为股东带来显著价值。

Closing Timeline And Further Details

结束时间表和更多细节

  • The merger between RIV Capital and Cansortium is expected to close by the fourth quarter of 2024, pending final closing conditions.
  • Upon completion, Cansortium's shares will continue trading on the Canadian Securities Exchange under the symbol 'TIUM.U' and on the OTCQB Venture Market under 'CNTMF.'
  • Further details, including the principal closing conditions, can be found in RIV Capital's management information circular dated July 12, 2024.
  • 预计RIV Capital和Cansortium之间的合并将在2024年第四季度完成,待最终交易条件满足。
  • 完成后,Cansortium的股票将继续在加拿大证券交易所以“TIUm.U”为标的以及在场外交易OTCQb创业公司市场以“CNTMF”为标的上交易。
  • 有关主要交易条件的进一步细节可在2024年7月12日的RIV Capital管理信息披露文件中找到。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发